Upgrade to SI Premium - Free Trial

Form EFFECT Acurx Pharmaceuticals,

September 18, 2026 6:03 AM
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 17, 2026 4:15 P.M.
Form: S-1
CIK: 0001736243
Company Name: Acurx Pharmaceuticals, Inc.
File Number: 333-298801

Categories

SEC Filings